133 related articles for article (PubMed ID: 27069134)
21. Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.
Nielsen TO; Friis-Hansen L; Poulsen SS; Federspiel B; Sorensen BS
PLoS One; 2014; 9(4):e94606. PubMed ID: 24728052
[TBL] [Abstract][Full Text] [Related]
22. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.
Elebro J; Heby M; Warfvinge CF; Nodin B; Eberhard J; Jirström K
PLoS One; 2016; 11(4):e0153533. PubMed ID: 27070783
[TBL] [Abstract][Full Text] [Related]
23. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
[TBL] [Abstract][Full Text] [Related]
24. Roles of human epidermal growth factor receptor family in pulmonary lymphangioleiomyomatosis.
Kobayashi K; Miki Y; Saito R; Adachi K; Seyama K; Okada Y; Sasano H
Hum Pathol; 2018 Nov; 81():121-130. PubMed ID: 30030119
[TBL] [Abstract][Full Text] [Related]
25. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
Gilbertson RJ; Perry RH; Kelly PJ; Pearson AD; Lunec J
Cancer Res; 1997 Aug; 57(15):3272-80. PubMed ID: 9242460
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of ErbB/HER family proteins in patients with vulvar cancer.
Baiocchi G; de Freitas RR; Bovolim G; Badiglian-Filho L; da Costa AABA; De Brot L
Int J Gynaecol Obstet; 2022 Apr; 157(1):102-109. PubMed ID: 34270807
[TBL] [Abstract][Full Text] [Related]
28. The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.
Strimpakos A; Pentheroudakis G; Kotoula V; De Roock W; Kouvatseas G; Papakostas P; Makatsoris T; Papamichael D; Andreadou A; Sgouros J; Zizi-Sermpetzoglou A; Kominea A; Televantou D; Razis E; Galani E; Pectasides D; Tejpar S; Syrigos K; Fountzilas G
Clin Colorectal Cancer; 2013 Dec; 12(4):267-274.e2. PubMed ID: 24050852
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
30. Characterization of EGFR family gene aberrations in cholangiocarcinoma.
Yang X; Wang W; Wang C; Wang L; Yang M; Qi M; Su H; Sun X; Liu Z; Zhang J; Qin X; Han B
Oncol Rep; 2014 Aug; 32(2):700-8. PubMed ID: 24927194
[TBL] [Abstract][Full Text] [Related]
31. EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.
Chan E; Alkhasawneh A; Duckworth LV; Aijaz T; Toro TZ; Lu X; Hughes SJ; Collinsworth A; George TJ
J Gastrointest Oncol; 2016 Dec; 7(6):838-847. PubMed ID: 28078108
[TBL] [Abstract][Full Text] [Related]
32. Low expression of HER2 protein in breast cancer is biologically significant.
Tovey SM; Reeves JR; Stanton P; Ozanne BW; Bartlett JM; Cooke TG
J Pathol; 2006 Nov; 210(3):358-62. PubMed ID: 16981252
[TBL] [Abstract][Full Text] [Related]
33. Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples.
Ho-Pun-Cheung A; Bazin H; Boissière-Michot F; Mollevi C; Simony-Lafontaine J; Landas E; Bleuse JP; Chardès T; Prost JF; Pèlegrin A; Jacot W; Mathis G; Lopez-Crapez E
Br J Cancer; 2020 Feb; 122(3):397-404. PubMed ID: 31792349
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.
Yonemori K; Tsuta K; Shimizu C; Hatanaka Y; Hirakawa A; Ono M; Kouno T; Katsumata N; Ando M; Tamura K; Hasegawa T; Kinoshita T; Fujiwara Y
J Surg Oncol; 2010 Mar; 101(3):222-7. PubMed ID: 20087905
[TBL] [Abstract][Full Text] [Related]
35. Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas.
Tang D; Liu CY; Shen D; Fan S; Su X; Ye P; Gavine PR; Yin X
Onco Targets Ther; 2015; 8():7-14. PubMed ID: 25565860
[TBL] [Abstract][Full Text] [Related]
36. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.
Witton CJ; Reeves JR; Going JJ; Cooke TG; Bartlett JM
J Pathol; 2003 Jul; 200(3):290-7. PubMed ID: 12845624
[TBL] [Abstract][Full Text] [Related]
37. The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients.
Memon AA; Sorensen BS; Meldgaard P; Fokdal L; Thykjaer T; Nexo E
Br J Cancer; 2006 Jun; 94(11):1703-9. PubMed ID: 16685269
[TBL] [Abstract][Full Text] [Related]
38. Association of HER1 amplification with poor prognosis in well differentiated gastric carcinomas.
Kandel C; Leclair F; Bou-Hanna C; Laboisse CL; Mosnier JF
J Clin Pathol; 2014 Apr; 67(4):307-12. PubMed ID: 24218028
[TBL] [Abstract][Full Text] [Related]
39. HER3 overexpression and survival in solid tumors: a meta-analysis.
Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
[TBL] [Abstract][Full Text] [Related]
40. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
